Curcumin (Longvida™) ( DrugBank: Curcumin )
1 disease
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 46 | Malignant rheumatoid arthritis | 1 |
46. Malignant rheumatoid arthritis
Clinical trials : 4,356 / Drugs : 2,567 - (DrugBank : 415) / Drug target genes : 192 - Drug target pathways : 228
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT00752154 (ClinicalTrials.gov) | January 2010 | 11/9/2008 | Curcumin in Rheumatoid Arthritis | Curcumin in Rheumatoid Arthritis - ACross-Over Pilot Study | Rheumatoid Arthritis | Drug: Curcumin (Longvida™) | University of California, Los Angeles | NULL | Recruiting | 18 Years | N/A | Both | 40 | Phase 0 | United States |